| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.9B | $8.8B | $8.4B | $9.0B | $8.4B | $2.0B | $1.8B | $1.8B |
| Cost of Revenue | $6.3B | $6.2B | $6.1B | $6.6B | $6.1B | $5.0B | $5.2B | $5.2B |
| Gross Profit | $2.5B | $2.5B | $2.3B | $2.4B | $2.3B | $0.6B | $0.5B | $0.5B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.4B | $1.4B | $1.3B | $1.3B | $1.2B | $1.1B | $1.1B | $1.1B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.7B | $0.7B | $0.5B | $0.8B | $0.7B | $0.6B | $0.3B | $0.5B |
| EPS (Basic) | $8.81 | $8.77 | $6.23 | $9.28 | $8.93 | $2.30 | $1.95 | $1.13 |
| EPS (Diluted) | $8.79 | $8.73 | $6.20 | $9.21 | $8.83 | $2.28 | $1.92 | $1.11 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.8B | $8.4B | $8.2B | $8.0B | $8.0B | $6.1B | $5.5B | $5.2B |
| Current Assets | $3.0B | $3.1B | $2.8B | $2.8B | $2.7B | $2.4B | $2.3B | $2.3B |
| Cash & Equivalents | $0.2B | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.7B | $2.9B | $2.7B | $2.8B | $2.5B | $1.9B | $2.3B | $2.0B |
| Stockholders' Equity | $2.2B | $2.3B | $2.1B | $2.0B | $1.9B | $1.5B | $1.2B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.9B | $0.8B | $1.0B | $1.0B | $0.8B | $0.7B | $0.5B |
| Investing Cash Flow | $-0.6B | $-0.2B | $-0.5B | $-0.3B | $-1.7B | $-0.6B | $-0.3B | $-0.2B |
| Capital Expenditures | $0.2B | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.4B | $-0.6B | $-0.3B | $-0.6B | $0.6B | $-0.2B | $-0.5B | $-0.2B |